MedPath

TILRAY, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
$1.4B
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Evaluating Safety and Efficacy of Cannabis in Participants With Chronic Posttraumatic Stress Disorder

Phase 2
Completed
Conditions
Posttraumatic Stress Disorder
Interventions
Drug: High THC/Low CBD Cannabis
Drug: High THC/High CBD Cannabis
Drug: Low THC/Low CBD Cannabis
First Posted Date
2015-08-07
Last Posted Date
2020-03-23
Lead Sponsor
Tilray
Target Recruit Count
6
Registration Number
NCT02517424
Locations
🇨🇦

University of British Columbia, Kelowna, British Columbia, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.